These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 36744397)

  • 21. Current treatment options for hereditary angioedema due to C1 inhibitor deficiency.
    Wu MA; Zanichelli A; Mansi M; Cicardi M
    Expert Opin Pharmacother; 2016; 17(1):27-40. PubMed ID: 26512744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The international WAO/EAACI guideline for the management of hereditary angioedema-The 2017 revision and update.
    Maurer M; Magerl M; Ansotegui I; Aygören-Pürsün E; Betschel S; Bork K; Bowen T; Balle Boysen H; Farkas H; Grumach AS; Hide M; Katelaris C; Lockey R; Longhurst H; Lumry WR; Martinez-Saguer I; Moldovan D; Nast A; Pawankar R; Potter P; Riedl M; Ritchie B; Rosenwasser L; Sánchez-Borges M; Zhi Y; Zuraw B; Craig T
    Allergy; 2018 Aug; 73(8):1575-1596. PubMed ID: 29318628
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent advances in management and treatment of hereditary angioedema.
    Sardana N; Craig TJ
    Pediatrics; 2011 Dec; 128(6):1173-80. PubMed ID: 22065270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral berotralstat for the prophylaxis of hereditary angioedema attacks in patients in Japan: A phase 3 randomized trial.
    Ohsawa I; Honda D; Suzuki Y; Fukuda T; Kohga K; Morita E; Moriwaki S; Ishikawa O; Sasaki Y; Tago M; Chittick G; Cornpropst M; Murray SC; Dobo SM; Nagy E; Van Dyke S; Reese L; Best JM; Iocca H; Collis P; Sheridan WP; Hide M
    Allergy; 2021 Jun; 76(6):1789-1799. PubMed ID: 33247955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. International consensus and practical guidelines on the gynecologic and obstetric management of female patients with hereditary angioedema caused by C1 inhibitor deficiency.
    Caballero T; Farkas H; Bouillet L; Bowen T; Gompel A; Fagerberg C; Bjökander J; Bork K; Bygum A; Cicardi M; de Carolis C; Frank M; Gooi JH; Longhurst H; Martínez-Saguer I; Nielsen EW; Obtulowitz K; Perricone R; Prior N;
    J Allergy Clin Immunol; 2012 Feb; 129(2):308-20. PubMed ID: 22197274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Administration of conestat alfa, human C1 esterase inhibitor and icatibant in the treatment of acute angioedema attacks in adults with hereditary angioedema due to C1 esterase inhibitor deficiency. Treatment comparison based on systematic review results].
    Kawalec P; Holko P; Paszulewicz A; Obtułowicz K
    Pneumonol Alergol Pol; 2013; 81(2):95-104. PubMed ID: 23420425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hereditary angioedema therapies in the United States: movement toward an international treatment consensus.
    Riedl M
    Clin Ther; 2012 Mar; 34(3):623-30. PubMed ID: 22386830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic and therapeutic management of hereditary angioedema due to C1-inhibitor deficiency: the Italian experience.
    Cancian M;
    Curr Opin Allergy Clin Immunol; 2015 Aug; 15(4):383-91. PubMed ID: 26106828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of hereditary angioedema-single or multiple pathways to the rescue.
    Valerieva A; Longhurst HJ
    Front Allergy; 2022; 3():952233. PubMed ID: 36172291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of pediatric hereditary angioedema types 1 and 2: A search for international consensus.
    Norris M; Ashoor Z; Craig T
    Allergy Asthma Proc; 2022 Sep; 43(5):388-396. PubMed ID: 36065112
    [No Abstract]   [Full Text] [Related]  

  • 31. New treatment options for acute edema attacks caused by hereditary angioedema.
    Thomas MC; Shah S
    Am J Health Syst Pharm; 2011 Nov; 68(22):2129-38. PubMed ID: 22058099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current medical management of hereditary angioedema: Follow-up survey of US physicians.
    Riedl MA; Banerji A; Gower R
    Ann Allergy Asthma Immunol; 2021 Mar; 126(3):264-272. PubMed ID: 33122123
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Orladeyo (Berotralstat): A Novel Oral Therapy for the Prevention of Hereditary Angioedema.
    Powell J; Piszczatoski C; Rubido E
    Ann Pharmacother; 2022 Apr; 56(4):488-493. PubMed ID: 34282650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hereditary and acquired angioedema.
    Patel G; Pongracic JA
    Allergy Asthma Proc; 2019 Nov; 40(6):441-445. PubMed ID: 31690390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modeling Cost-Effectiveness of On-Demand Treatment for Hereditary Angioedema Attacks.
    Bernstein JA; Tyson C; Relan A; Adams P; Magar R
    J Manag Care Spec Pharm; 2020 Feb; 26(2):203-210. PubMed ID: 31841366
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Icatibant for the treatment of hereditary angioedema.
    Cole SW; Lundquist LM
    Ann Pharmacother; 2013 Jan; 47(1):49-55. PubMed ID: 23249729
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hereditary angioedema: Long-term prophylactic treatment.
    Li HH
    Allergy Asthma Proc; 2020 Nov; 41(Suppl 1):S35-S37. PubMed ID: 33109324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Update on treatment of hereditary angioedema.
    Buyantseva LV; Sardana N; Craig TJ
    Asian Pac J Allergy Immunol; 2012 Jun; 30(2):89-98. PubMed ID: 22830287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical manifestations, diagnosis, and treatment of hereditary angioedema: survey data from 94 physicians in Japan.
    Ohsawa I; Honda D; Nagamachi S; Hisada A; Shimamoto M; Inoshita H; Mano S; Tomino Y
    Ann Allergy Asthma Immunol; 2015 Jun; 114(6):492-8. PubMed ID: 25872948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant human C1 esterase inhibitor in the management of hereditary angioedema.
    Riedl M
    Clin Drug Investig; 2015 Jul; 35(7):407-17. PubMed ID: 26091744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.